SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cell MedX Corp. – ‘10-Q’ for 11/30/20 – ‘EXCEL’

On:  Thursday, 1/14/21, at 5:07pm ET   ·   For:  11/30/20   ·   Accession #:  1393905-21-10   ·   File #:  0-54500

Previous ‘10-Q’:  ‘10-Q’ on 10/15/20 for 8/31/20   ·   Next:  ‘10-Q’ on 4/9/21 for 2/28/21   ·   Latest:  ‘10-Q’ on 4/15/24 for 2/29/24   ·   31 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/14/21  Cell MedX Corp.                   10-Q       11/30/20   53:2M                                     Empire Stock Transf… Inc

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    286K 
 2: EX-10.30    Loan Agreement and Note Payable Dated September 2,  HTML     19K 
                2020, Among Cell Medx Corp. and Rain                             
                Communications Corp.                                             
 3: EX-10.31    Loan Agreement and Note Payable Dated October 26,   HTML     20K 
                2020, Among Cell Medx Corp. and Rain                             
                Communications Corp.                                             
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     18K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     18K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     16K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     16K 
14: R1          Document and Entity Information                     HTML     64K 
15: R2          Condensed Consolidated Balance Sheets               HTML     82K 
16: R3          Condensed Consolidated Balance Sheets -             HTML     23K 
                Parenthetical                                                    
17: R4          Condensed Consolidated Statements of Operations     HTML     74K 
18: R5          Condensed Consolidated Statement of Stockholders'   HTML     60K 
                Deficit                                                          
19: R6          Condensed Consolidated Statements of Cash Flows     HTML     83K 
20: R7          Organization and Nature of Operations               HTML     22K 
21: R8          Related Party Transactions Disclosure               HTML     31K 
22: R9          Inventory Disclosure                                HTML     18K 
23: R10         Other Current Assets Disclosure                     HTML     18K 
24: R11         Equipment Disclosure                                HTML     23K 
25: R12         Revenue Disclosure                                  HTML     26K 
26: R13         Notes and Advances Payable Disclosure               HTML     38K 
27: R14         Share Capital Disclosure                            HTML     40K 
28: R15         Related Party Transactions Disclosure: Schedule of  HTML     24K 
                Amounts Due to Related Parties (Tables)                          
29: R16         Related Party Transactions Disclosure: Schedule of  HTML     22K 
                Transactions with Related Parties (Tables)                       
30: R17         Equipment Disclosure: Change in book value of the   HTML     22K 
                equipment (Tables)                                               
31: R18         Revenue Disclosure: Schedule of Revenue and         HTML     26K 
                Associated Costs (Tables)                                        
32: R19         Notes and Advances Payable Disclosure: Schedule of  HTML     33K 
                Short-term Loans and Advances Outstanding (Tables)               
33: R20         Share Capital Disclosure: Schedule of Stock Option  HTML     24K 
                Activity (Tables)                                                
34: R21         Share Capital Disclosure: Schedule of Stock         HTML     22K 
                Options Outstanding (Tables)                                     
35: R22         Share Capital Disclosure: Schedule of Warrant       HTML     24K 
                Activity (Tables)                                                
36: R23         Share Capital Disclosure: Schedule of Warrant       HTML     23K 
                Details (Tables)                                                 
37: R24         Organization and Nature of Operations (Details)     HTML     20K 
38: R25         Related Party Transactions Disclosure: Schedule of  HTML     33K 
                Amounts Due to Related Parties (Details)                         
39: R26         Related Party Transactions Disclosure: Schedule of  HTML     26K 
                Transactions with Related Parties (Details)                      
40: R27         Inventory Disclosure (Details)                      HTML     21K 
41: R28         Other Current Assets Disclosure (Details)           HTML     20K 
42: R29         Equipment Disclosure: Change in book value of the   HTML     26K 
                equipment (Details)                                              
43: R30         Revenue Disclosure: Schedule of Revenue and         HTML     35K 
                Associated Costs (Details)                                       
44: R31         Notes and Advances Payable Disclosure: Schedule of  HTML     44K 
                Short-term Loans and Advances Outstanding                        
                (Details)                                                        
45: R32         Notes and Advances Payable Disclosure (Details)     HTML     34K 
46: R33         Share Capital Disclosure (Details)                  HTML     29K 
47: R34         Share Capital Disclosure: Schedule of Stock Option  HTML     26K 
                Activity (Details)                                               
48: R35         Share Capital Disclosure: Schedule of Stock         HTML     28K 
                Options Outstanding (Details)                                    
49: R36         Share Capital Disclosure: Schedule of Warrant       HTML     25K 
                Activity (Details)                                               
50: R37         Share Capital Disclosure: Schedule of Warrant       HTML     33K 
                Details (Details)                                                
52: XML         IDEA XML File -- Filing Summary                      XML     89K 
51: EXCEL       IDEA Workbook of Financial Reports                  XLSX     44K 
 8: EX-101.INS  XBRL Instance -- cmxc-20201130                       XML    553K 
10: EX-101.CAL  XBRL Calculations -- cmxc-20201130_cal               XML     60K 
11: EX-101.DEF  XBRL Definitions -- cmxc-20201130_def                XML    235K 
12: EX-101.LAB  XBRL Labels -- cmxc-20201130_lab                     XML    436K 
13: EX-101.PRE  XBRL Presentations -- cmxc-20201130_pre              XML    372K 
 9: EX-101.SCH  XBRL Schema -- cmxc-20201130                         XSD    100K 
53: ZIP         XBRL Zipped Folder -- 0001393905-21-000010-xbrl      Zip     51K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


16 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/16/24  Cell MedX Corp.                   10-Q       11/30/23   46:2.3M                                   Empire Stock Transf… Inc
10/16/23  Cell MedX Corp.                   10-Q        8/31/23   42:1.9M                                   Empire Stock Transf… Inc
 9/01/23  Cell MedX Corp.                   10-K        5/31/23   73:3.2M                                   Empire Stock Transf… Inc
 6/29/23  Cell MedX Corp.                   10-Q        2/28/23   53:2.5M                                   Empire Stock Transf… Inc
 5/19/23  Cell MedX Corp.                   10-Q       11/30/22   53:2.4M                                   Empire Stock Transf… Inc
 4/19/23  Cell MedX Corp.                   10-Q        8/31/22   51:2.2M                                   Empire Stock Transf… Inc
 4/07/23  Cell MedX Corp.                   10-K        5/31/22   90:3.6M                                   Empire Stock Transf… Inc
 4/11/22  Cell MedX Corp.                   10-Q        2/28/22   56:2.5M                                   Empire Stock Transf… Inc
 1/12/22  Cell MedX Corp.                   10-Q       11/30/21   54:2.4M                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   424B3                  1:365K                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   10-Q        8/31/21   50:2.2M                                   Empire Stock Transf… Inc
10/12/21  Cell MedX Corp.                   424B3                  1:705K                                   Empire Stock Transf… Inc
 8/30/21  Cell MedX Corp.                   10-K        5/31/21   83:3.7M                                   Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   424B3                  1:501K                                   Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   10-Q        2/28/21   56:2.8M                                   Empire Stock Transf… Inc
 3/04/21  Cell MedX Corp.                   S-1                   78:3.8M                                   Empire Stock Transf… Inc


15 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/15/20  Cell MedX Corp.                   10-K        5/31/20   84:2.9M                                   Empire Stock Transf… Inc
 4/14/20  Cell MedX Corp.                   10-Q        2/29/20   67:2.2M                                   Empire Stock Transf… Inc
 1/31/20  Cell MedX Corp.                   8-K:1,9     1/29/20    3:69K                                    Empire Stock Transf… Inc
 1/14/20  Cell MedX Corp.                   10-Q       11/30/19   65:2.2M                                   Empire Stock Transf… Inc
12/31/18  Cell MedX Corp.                   8-K:1,3,9  12/27/18    3:248K                                   Empire Stock Transf… Inc
 9/13/18  Cell MedX Corp.                   10-K        5/31/18   85:3M                                     Empire Stock Transf… Inc
10/17/17  Cell MedX Corp.                   10-Q        8/31/17   59:2.2M                                   Empire Stock Transf… Inc
 8/11/15  Cell MedX Corp.                   8-K:5,9     8/11/15    3:172K                                   Ideal Connection, Inc/FA
11/18/14  Cell MedX Corp.                   8-K:1,9    11/13/14    2:48K                                    Ideal Connection, Inc/FA
11/03/14  Cell MedX Corp.                   8-K:1,9    10/28/14    2:60K                                    Ideal Connection, Inc/FA
10/17/14  Cell MedX Corp.                   8-K:1,9    10/16/14    3:407K                                   Ideal Connection, Inc/FA
10/09/14  Cell MedX Corp.                   10-Q        8/31/14   37:2.9M                                   Ideal Connection, Inc/FA
 8/26/14  Cell MedX Corp.                   10-K        5/31/14   37:1.8M                                   Ideal Connection, Inc/FA
10/13/10  Cell MedX Corp.                   S-1/A                  8:1.2M                                   Toppan Merrill/FA
 7/13/10  Cell MedX Corp.                   S-1                   11:921K                                   Toppan Merrill/FA
Top
Filing Submission 0001393905-21-000010   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 12:56:07.2pm ET